G43.709 coverage policies: Medicare and commercial payers

49 active Medicare policies list G43.709, and 3 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.

Get free alerts for G43.709

Free account. Policy pages stay open to everyone.

Medicare policies listing G43.709

LCD · CGS-J15-L39856

Botulinum Toxin Injections

J15

LCD · CGS-J15-L39857

Botulinum Toxin Injections

J15 · Effective Feb 22, 2026

LCD · NGS-J6-L39832

Botulinum Toxin Injections

J6 · Effective Feb 22, 2026

LCD · NGS-JK-L39832

Botulinum Toxin Injections

JK · Effective Feb 22, 2026

LCD · NORIDIAN-L35170

Botulinum Toxin Injections

JE · Effective Oct 1, 2015

LCD · NORIDIAN-L35172

Botulinum Toxin Injections

JF · Effective Oct 1, 2015

LCD · PALMETTO-JJ-L39836

Botulinum Toxin Injections

JJ · Effective Feb 22, 2026

LCD · PALMETTO-JM-L39836

Botulinum Toxin Injections

JM · Effective Feb 22, 2026

LCD · WPS-J5-L39908

Botulinum Toxin Injections

LCD · WPS-J5-L39909

Botulinum Toxin Injections

J5 · Effective Feb 22, 2026

LCD · WPS-J5-L40381

Commercial payer policies listing G43.709

3 policies from 3 payers

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Ambetter

Ambetter policies listing G43.709, with the code’s status in each
Policy	Effective	Status of G43.709
Visual Field TestingPayerPolicy · AMBETTER-CP-VP-63	Not recorded	Covered

Cigna

Cigna policies listing G43.709, with the code’s status in each
Policy	Effective	Status of G43.709
Peripheral Nerve Destruction for Pain ConditionsPayerPolicy · CIGNA-0525	Sep 15, 2026	Not covered

UnitedHealthcare

UnitedHealthcare policies listing G43.709, with the code’s status in each
Policy	Effective	Status of G43.709
Vyepti (Eptinezumab-Jjmr)PayerPolicy · UHC-POL-vyepti	Sep 1, 2026	Covered